Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-30 12:11 pm Purchase | 2023-04-20 | 13G | Stryve Foods, Inc. SNAX | LYTTON LAURENCE W | 191,501 9.990% | 191,501 (New Position) | Filing History |
| 2023-05-22 4:13 pm Purchase | 2023-05-11 | 13G | Rail Vision Ltd. RVSN | LYTTON LAURENCE W | 197,500 7.900% | 197,500 (New Position) | Filing History |
| 2023-05-11 5:06 pm Purchase | 2023-05-02 | 13G | Miromatrix Medical Inc. MIRO | LYTTON LAURENCE W | 1,380,367 5.100% | 1,380,367 (New Position) | Filing History |
| 2023-03-07 5:22 pm Sale | 2022-12-31 | 13G | Scientific Industries, Inc. SCND | LYTTON LAURENCE W | 394,679 5.500% | -195,529 (-33.13%) | Filing History |
| 2023-02-22 1:40 pm Purchase | 2023-02-09 | 13G | aTyr Pharma, Inc. ATYR | LYTTON LAURENCE W | 4,440,188 8.700% | 4,440,188 (New Position) | Filing History |
| 2023-02-13 4:41 pm Purchase | 2022-12-31 | 13G | Duos Technologies Group, Inc. DUOT | LYTTON LAURENCE W | 634,025 8.900% | 419,325 (+195.31%) | Filing History |
| 2023-02-13 4:31 pm Purchase | 2022-12-31 | 13G | Giga-tronics Incorporated GIGA | LYTTON LAURENCE W | 603,700 9.990% | 328,749 (+119.57%) | Filing History |
| 2023-02-13 4:22 pm Purchase | 2022-12-31 | 13G | LiqTech International, Inc. LIQT | LYTTON LAURENCE W | 566,679 9.990% | 290,432 (+105.14%) | Filing History |
| 2023-02-13 4:13 pm Purchase | 2022-12-31 | 13G | Scientific Industries, Inc. SCND | LYTTON LAURENCE W | 590,208 8.300% | 181,979 (+44.58%) | Filing History |
| 2023-02-13 4:03 pm Sale | 2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | LYTTON LAURENCE W | 125,029 8.400% | -477 (-0.38%) | Filing History |
| 2023-02-13 3:54 pm Sale | 2022-12-31 | 13G | VERTEX ENERGY INC VTNRQ | LYTTON LAURENCE W | 513,330 0.700% | -3,135,737 (-85.93%) | Filing History |
| 2023-02-13 3:47 pm Purchase | 2022-12-31 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 871,181 5.300% | 37,876 (+4.55%) | Filing History |
| 2023-02-13 3:40 pm Sale | 2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK | LYTTON LAURENCE W | 459,961 0.800% | -2,750,591 (-85.67%) | Filing History |
| 2023-02-13 3:33 pm Sale | 2022-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | LYTTON LAURENCE W | 0 0.000% | -6,260,292 (Position Closed) | Filing History |
| 2023-02-13 3:24 pm Sale | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | LYTTON LAURENCE W | 3,403,180 6.700% | -286,740 (-7.77%) | Filing History |
| 2023-02-13 3:14 pm Purchase | 2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 482,430 4.990% | 64,651 (+15.47%) | Filing History |
| 2023-02-13 2:55 pm Sale | 2022-12-31 | 13G | Catalyst Biosciences, Inc. CBIO | LYTTON LAURENCE W | 177,822 7.100% | -294,793 (-62.37%) | Filing History |
| 2023-02-10 7:02 pm Purchase | 2022-12-31 | 13G | EMCORE Corporation EMKR | LYTTON LAURENCE W | 292,327 7.800% | 87,937 (+43.02%) | Filing History |
| 2023-01-19 6:34 pm Purchase | 2023-01-10 | 13G | BIOLASE, Inc. BIOL | LYTTON LAURENCE W | 24,611 9.990% | 24,611 (New Position) | Filing History |
| 2022-11-23 2:40 pm Purchase | 2022-11-14 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 833,305 5.100% | 833,305 (New Position) | Filing History |